GKCC, LLC

Overview

• HeadquartersDE¹

See how the biggest companies compare on our leaderboards

Corporate structure

GKCC, LLC sits at the top of its group. 5 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Built from major holders from Schedules 13D and 13G; stakes of 5% or more it reported on Schedules 13D and 13G (4 companies). Each entity in the chart links to its source.

Filings

1 filings to the SEC since October 2021: 1 large holders. The latest 1:

1. Sep 22, 2023SC 13G SCHEDULE 13G EDGAR

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

1 such filings since October 2021:

1. Sep 22, 2023SC 13G

Stakes it holds

GKCC, LLC has told the SEC it owns more than 5% of 4 companies, latest first (Schedules 13D and 13G).

• Elicio Therapeutics, Inc.SCHEDULE 13D/A Jun 14, 2023 to Jun 4, 2025²
• Xilio Therapeutics, Inc.SC 13G Sep 27, 2024³
• MiNK Therapeutics, Inc.SC 13G May 22, 2024⁴
• Immix Biopharma, Inc.SC 13D Aug 30, 2023⁵